Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.
about
The Foxc2 transcription factor regulates tumor angiogenesisMolecular mediators of angiogenesis.Targeting the PDGF signaling pathway in tumor treatmentPleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.Conditional ablation of macrophages disrupts ovarian vasculature.PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulationAssociation between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialProtective Effects of N-Acetyl Cysteine against Diesel Exhaust Particles-Induced Intracellular ROS Generates Pro-Inflammatory Cytokines to Mediate the Vascular Permeability of Capillary-Like Endothelial Tubes.Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome).AXL is an essential factor and therapeutic target for metastatic ovarian cancerImpaired angiogenesis in the enalapril-treated neonatal rat kidney.Pericytes on the tumor vasculature: jekyll or hyde?Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancerVEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survivalCytokines and angiogenesis in the corpus luteumPericyte-fibroblast transition promotes tumor growth and metastasis.AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR.Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitorsTranscriptional targeting of tumor endothelial cells for gene therapy.Locally existing endothelial cells and pericytes in ovarian stroma, but not bone marrow-derived vascular progenitor cells, play a central role in neovascularization during follicular development in mice.Growth factors as active participants in carcinogenesis: a perspective.TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.Human blood-vessel-derived stem cells for tissue repair and regeneration.Cellular kinetics of perivascular MSC precursors.Heparan sulfate in angiogenesis: a target for therapy.Restoring TRAIL mediated signaling in ovarian cancer cells.Pericytes: a double-edged sword in cancer therapy.A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy.Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice.Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation.The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis.Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.Low differentiated microvascular density and low expression of platelet-derived growth factor-BB (PDGF-BB) predict distant metastasis and poor prognosis in clear cell renal cell carcinoma.CD11c+ M1-like macrophages (MΦs) but not CD206+ M2-like MΦ are involved in folliculogenesis in mice ovary.
P2860
Q24647592-0B1A06BC-2927-423A-BAFE-0A9F04A1BB0CQ33639474-C0DB7705-AE4F-456E-8EE1-B94BC20B981BQ34393461-16730FF5-B6A8-49A7-BC0D-7E2EBC22242EQ34497997-7F4E8CF4-C3A6-445D-AD06-F0DD9B90B66AQ34760581-FF926C33-9F22-445B-BD95-063517A814FEQ34972161-84919485-C744-4474-9A08-E67F4C407988Q35005295-AE378633-44BA-4F65-9D9E-8B03A4061CB4Q35531393-EDDE6328-4263-45FA-92A4-F291CCE76679Q35562771-E49B654F-4606-41C9-8BD5-4D6BBFACFC61Q35684135-D5ED1913-792E-466F-A7CB-9B5F2BE418B5Q35986651-BE85BD1A-D1E9-4406-826A-4C9226DF862DQ36127308-1A10AA22-C5AE-40AE-9088-22D2275D78A0Q36578942-F881AD34-2B43-44EB-82F5-C9F9B0A65ABAQ36695062-46347FD5-103B-4D00-B2B3-A76A8347F00DQ36759226-AEED8BCA-50DF-4DD2-B422-E1EB16C8B8F1Q36948947-23B9C83C-C9E5-4719-B00A-295A05BDFC55Q36956102-59F5A291-9310-4BB3-B945-72F6F435C3F8Q37281490-7911E8F6-06A2-4355-97A3-7D383ADF36B8Q37296212-BE40B097-2928-4994-B677-8697D88787AAQ37382109-439F644C-30A1-457B-BABB-AE77313AE2C2Q37459648-129B0F2E-4108-494B-BD58-6B6A0A824D30Q37528947-1D433F9D-9EB0-4FFF-AC25-CAF28DE6FE04Q37676697-DD225B5C-350A-4F83-8784-7875DE4E59D4Q37722129-DB4EB51C-DCE2-4973-879B-DBF81A3114FFQ37847073-3EC4FC9A-F319-4223-AA90-4FABF74F076DQ38002402-AC08617A-A961-44DD-890D-922EBB9E7C7CQ38136188-A93AF251-005C-4B02-A031-D3193535E88AQ38154506-045B222B-D9DD-436D-9130-3275DDF02A92Q38230205-07FFB057-C702-4953-B824-0E91A37D9DC4Q38241791-A4367CD2-B8AF-4E42-B824-9C3DC24602B1Q38718622-E2B10C22-7431-4E07-8D74-D0CD7683B2B6Q38974204-4A9CDD54-B077-4DA0-B95A-CD7A47A6E748Q39652101-2A6E7B45-F41F-4C16-9EE1-397E28D7DF0FQ39745485-77DAF4C8-99F8-4F8B-9942-F1039BC162D9Q45161318-17872E0D-1138-4F1A-8D88-0EFD4306E18DQ46092429-73103843-F776-459D-AFEB-A93688907234Q46120257-2A79B58B-2619-4FC0-ABCB-EFDA755E2932Q55334506-3347F831-562F-435C-A70D-407356ECE793
P2860
Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@ast
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@en
type
label
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@ast
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@en
prefLabel
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@ast
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@en
P2093
P2860
P356
P1476
Soluble receptor-mediated sele ...... ologic and tumor angiogenesis.
@en
P2093
Angeline Jocson
Barbara Sennino
Betty Y Y Tam
Calvin J Kuo
Donald M McDonald
Frank Kuhnert
Jenny Yuan
John T Gray
Nihar R Nayak
Richard C Mulligan
P2860
P304
10185-10190
P356
10.1073/PNAS.0803194105
P407
P577
2008-07-16T00:00:00Z